CorMedix Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,594.50
4,339.50
35,557.40
20,337.00
12,155.50
17,795.30
Total Accounts Receivable
2.30
80.20
315.80
12.00
64.10
10.90
Inventories
80.00
463.00
376.60
166.70
594.20
428.50
Other Current Assets
239.20
155.20
809.20
1,316.00
453.80
430.30
Total Current Assets
2,916.00
5,038.00
37,058.90
21,831.70
13,267.70
18,665.10
Net Property, Plant & Equipment
36.10
41.50
37.90
69.70
186.30
160.90
Total Investments and Advances
-
18.30
5.00
5.00
-
-
Other Assets
15.70
-
-
-
-
-
Total Assets
2,967.80
5,097.80
37,101.70
21,906.40
13,453.90
18,825.90
Accounts Payable
939.80
893.40
1,709.40
1,645.30
1,808.30
Other Current Liabilities
734.30
532.00
1,352.00
2,446.60
4,452.30
Total Current Liabilities
1,674.10
1,425.40
3,061.40
4,091.90
6,260.60
Other Liabilities
5,316.10
37.90
28.90
-
-
Total Liabilities
6,990.10
1,463.30
3,090.20
4,091.90
6,260.60
Common Equity (Total)
4,023.20
3,633.50
34,011.00
17,814.10
7,192.90
Total Shareholders' Equity
4,022.30
3,634.50
34,011.50
17,814.50
7,193.40
Total Equity
4,022.30
3,634.50
34,011.50
17,814.50
7,193.40
Liabilities & Shareholders' Equity
2,967.80
5,097.80
37,101.70
21,906.40
13,453.90
Preferred Stock (Carrying Value)
0.90
1.00
0.50
0.50
0.40

About CorMedix

View Profile
Address
400 Connell Drive
Berkeley Heights New Jersey 07921
United States
Employees -
Website http://www.cormedix.com
Updated 07/08/2019
CorMedix, Inc. operates as a pharmaceutical and medical device company that seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E.